Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17


Anticipated health behaviour changes and perceived control in response to disclosure of genetic risk of breast and ovarian cancer: a quantitative survey study among women in the UK.

Meisel SF, Fraser LSM, Side L, Gessler S, Hann KEJ, Wardle J, Lanceley A; PROMISE study team.

BMJ Open. 2017 Dec 22;7(12):e017675. doi: 10.1136/bmjopen-2017-017675.


Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.

Levin T, Mæhle L.

Fam Cancer. 2017 Apr;16(2):257-265. doi: 10.1007/s10689-016-9939-8.


Timing and context: important considerations in the return of genetic results to research participants.

McBride KA, Hallowell N, Tattersall MH, Kirk J, Ballinger ML, Thomas DM, Mitchell G, Young MA.

J Community Genet. 2016 Jan;7(1):11-20. doi: 10.1007/s12687-015-0231-7. Epub 2015 May 26.


The attitudes of people with sarcoma and their family towards genomics and incidental information arising from genetic research.

Young MA, Herlihy A, Mitchell G, Thomas DM, Ballinger M, Tucker K, Lewis CR, Neuhaus S; International Sarcoma Kindred Study, Halliday J.

Clin Sarcoma Res. 2013 Jul 30;3(1):11. doi: 10.1186/2045-3329-3-11.


Linguistic indicators of patient, couple, and family adjustment following breast cancer.

Robbins ML, Mehl MR, Smith HL, Weihs KL.

Psychooncology. 2013 Jul;22(7):1501-8. doi: 10.1002/pon.3161. Epub 2012 Aug 13.


A randomized trial of genetic and environmental risk assessment (GERA) for colorectal cancer risk in primary care: trial design and baseline findings.

Myers RE, Manne SL, Wilfond B, Sifri R, Ziring B, Wolf TA, Cocroft J, Ueland A, Petrich A, Swan H, DiCarlo M, Weinberg DS.

Contemp Clin Trials. 2011 Jan;32(1):25-31. doi: 10.1016/j.cct.2010.08.013. Epub 2010 Sep 7.


A decade of genetic counseling in frontotemporal dementia affected families: few counseling requests and much familial opposition to testing.

Riedijk SR, Niermeijer MF, Dooijes D, Tibben A.

J Genet Couns. 2009 Aug;18(4):350-6. doi: 10.1007/s10897-009-9222-3. Epub 2009 Apr 10.


Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.

Gray SW, O'Grady C, Karp L, Smith D, Schwartz JS, Hornik RC, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1303-11. doi: 10.1158/1055-9965.EPI-08-0825. Epub 2009 Mar 24.


Factors influencing parental decision about genetics evaluation for their deaf or hard-of-hearing child.

Palmer CG, Lueddeke JT, Zhou J.

Genet Med. 2009 Apr;11(4):248-55. doi: 10.1097/GIM.0b013e318195aad9.


Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.

Metcalfe KA, Fan I, McLaughlin J, Risch HA, Rosen B, Murphy J, Bradley L, Armel S, Sun P, Narod SA.

Gynecol Oncol. 2009 Jan;112(1):68-72. doi: 10.1016/j.ygyno.2008.10.007. Epub 2008 Nov 20.


Incidental findings in genetics research using archived DNA.

Clayton EW.

J Law Med Ethics. 2008 Summer;36(2):286-91, 212. doi: 10.1111/j.1748-720X.2008.00271.x.


Testicular cancer and genetics knowledge among familial testicular cancer family members.

Peters JA, Beckjord EB, Banda Ryan DR, Carr AG, Vadaparampil ST, Loud JT, Korde L, Greene MH.

J Genet Couns. 2008 Aug;17(4):351-64. doi: 10.1007/s10897-008-9153-4. Epub 2008 May 15.


Women's views on chemoprevention of breast cancer: qualitative study.

Heisey R, Pimlott N, Clemons M, Cummings S, Drummond N.

Can Fam Physician. 2006 May;52:624-5.


Acceptance of genetic testing for hereditary breast ovarian cancer among study enrollees from an African American kindred.

Kinney AY, Simonsen SE, Baty BJ, Mandal D, Neuhausen SL, Seggar K, Holubkov R, Smith K.

Am J Med Genet A. 2006 Apr 15;140(8):813-26.


Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Timman R, Stijnen T, Tibben A.

J Med Genet. 2004 Jul;41(7):e100. Review.

Supplemental Content

Support Center